Taken together, we present an in vitro model of acquired resistance to DOT1L inhibition in KMT2A-rearranged ALL, revealing selective loss of epigenetic regulation and gene expression of KMT2A-fusion target genes, accompanied by upregulation of myeloid-like characteristics. This evidence concerns the gene DOT1L and acute lymphoblastic leukemia.